Empagliflozin, metformin (Synjardy)
Empagliflozin, metformin
Ingelheim Pharmaceuticals (Pty) Ltd û Ferndale
Registration
- Applicant
- Ingelheim Pharmaceuticals (Pty) Ltd û Ferndale
- Registrations
- 6
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Synjardy 5/500mg EACH TABLET CONTAINS: EMPAGLIFLOZIN 5,0 mg, METFORMIN HYDROCHLORIDE 500,0 mg | 5/500mg | 49091549/21.2/0915 | Registered | Not determined | None |
| Synjardy 5/ 850mg EACH TABLET CONTAINS: EMPAGLIFLOZIN 5,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 5/ 850mg | 49091649/21.2/0916 | Registered | Not determined | None |
| Synjardy 5/ 1000 MG EACH TABLET CONTAINS: EMPAGLIFLOZIN 5,0 mg METFORMIN HYDROCHLORIDE 1000,0 mg | 5/ 1000 mg | 49091749/21.2/0917 | Registered | Not determined | None |
| Synjardy 12,5/500 MG EACH TABLET CONTAINS: EMPAGLIFLOZIN 12,5 mg METFORMIN HYDROCHLORIDE 500,0 mg | 12,5/500 mg | 49091849/21.2/0918 | Registered | Not determined | None |
| Synjardy 12,5/ 850 MG EACH TABLET CONTAINS: EMPAGLIFLOZIN 12,5 mg METFORMIN HYDROCHLORIDE 850,0 mg | 12,5/ 850 mg | 49091949/21.2/0919 | Registered | Not determined | None |
| Synjardy 12,5/1000mg EACH TABLET CONTAINS: EMPAGLIFLOZIN 12,5 mg METFORMIN HYDROCHLORIDE 1000,0 mg | 12,5/1000mg | 49092049/21.2/0920 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Empagliflozin
Consolidated Schedules 06 July 2026, line 6176
S3: Metformin
Consolidated Schedules 06 July 2026, line 3938
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.